Impaired transactivation of the human CYP2J2 arachidonic acid epoxygenase gene in HepG2 cells subjected to nitrative stress: Research paper

British Journal of Pharmacology

Volumn 159, Issue 7, 2010, Pages 1440-1449

  Cui, Pei H ^a   Lee, Andy C ^a   Zhou, Fanfan ^a   Murray, Michael ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Activator protein 1; Cytochrome P450 2J2; Epoxyfatty acids; Gene regulation; Nitrative stress

Indexed keywords

CYTOCHROME P450 2J2; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; NITROPRUSSIDE SODIUM; PROTEIN C FOS; PROTEIN C JUN; TRANSCRIPTION FACTOR AP 1;

ARTICLE; CELL STRAIN HEPG2; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; HUMAN; HUMAN CELL; LIVER MICROSOME; NITRATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSACTIVATION; UPREGULATION;

BASE SEQUENCE; CELL LINE, TUMOR; CYTOCHROME P-450 ENZYME SYSTEM; DNA PRIMERS; DOWN-REGULATION; ELECTROPHORETIC MOBILITY SHIFT ASSAY; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASES; NITRATES; NITROPRUSSIDE; POLYMERASE CHAIN REACTION; PROMOTER REGIONS, GENETIC; TRANSCRIPTIONAL ACTIVATION;

EID: 77949779917     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2009.00628.x     Document Type: Article

References (42)

1. Batchu SN, Law E, Brocks DR, Falck JR, Seubert JM (2009). Epoxyeicosatrienoic acid prevents postischemic electrocardiogram abnormalities in an isolated heart model. J Mol Cell Cardiol 46: 67 74.
2. Bernstrom K, Kayganich K, Murphy RC, Fitzpatrick FA (1992). Incorporation and distribution of epoxyeicosatrienoic acids into cellular phospholipids. J Biol Chem 267: 3638 3690.
3. Bogoyevitch MA, Court NW (2004). Counting on mitogen-activated protein kinases - ERKs 3, 4, 5, 6, 7 and 8. Cell Signal 16: 1345 1354.
4. Boutros T, Chevet E, Matrakos P (2008). Mitogen-activated protein (MAP) kinase/MAP kinase phosphatase regulation: roles in cell growth, death, and cancer. Pharmacol Rev 60: 261 310.
5. Callsen D, Brüne B (1999). Role of mitogen-activated protein kinases in S-nitrosoglutathione-induced macrophage apoptosis. Biochemistry 38: 2279 2286.
6. Chen JK, Capdevila J, Harris RC (2001). Cytochrome P450 epoxygenase metabolism of arachidonic acid inhibits apoptosis. Mol Cell Biol 21: 6322 6331.
7. Chung MJ, Hogstrand C, Lee SJ (2006). Cytotoxicity of nitric oxide is alleviated by zinc-mediated expression of antioxidant genes. Exp Biol Med 231: 1555 1563.
8. Feng GJ, Goodridge HS, Harnett MM, Wei XQ, Nikolaev AV, Higson AP et al. (1999). Extracellular signal-related kinase (ERK) and p38 mitogen-activated protein (MAP) kinases differentially regulate the lipopolysaccharide-mediated induction of inducible nitric oxide synthase and IL-12 in macrophages: Leishmania phosphoglycans subvert macrophage IL-12 production by targeting ERK MAP kinase. J Immunol 163: 6403 6412.
9. Fleming I (2001). Cytochrome P450 enzymes in vascular homeostasis. Circ Res 89: 753 762.
10. Gaedigk A, Baker DW, Totah RA, Gaedigk R, Pearce RE, Vyhlidal CA et al. (2006). Variability of CYP2J2 expression in human fetal tissues. J Pharmacol Exp Ther 319: 523 532.
11. Gryglewski RJ, Palmer RMJ, Moncada S (1986). Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature 320: 454 456.
12. Hashizume T, Imaoka S, Mise M, Terauchi Y, Fujii T, Miyazaki H et al. (2002). Involvement of CYP2J2 and CYP4F12 in the metabolism of ebastine in human intestinal microsomes. J Pharmacol Exp Ther 300: 298 304.
13. Horiike S, Kawanishi S, Kaito M, Ma N, Tanaka H, Fujita N et al. (2005). Accumulation of 8-nitroguanine in the liver of patients with chronic hepatitis C. J Hepatol 43: 403 410.
14. Jiang JG, Chen CL, Card JW, Yang S, Chen JX, Fu XN et al. (2005). Cytochrome P450 2J2 promotes the neoplastic phenotype of carcinoma cells and is up-regulated in human tumors. Cancer Res 65: 4707 4715.
15. Jun CD, Oh CD, Kwak HJ, Pae HO, Yoo JC, Choi BM et al. (1999a). Overexpression of protein kinase C isoforms protects RAW264.7 macrophages from nitric oxide-induced apoptosis: involvement of c-Jun N-terminal kinase/stress-activated protein kinase, p38 kinase and CPP32 protease pathways. J Immunol 162: 3395 3401.
16. Jun CD, Pae HO, Kwak HJ, Yoo JC, Choi BM, Oh CD et al. (1999b). Modulation of nitric oxide-induced apoptotic death of HL-60 cells by protein kinase C and protein kinase A through mitogen-activated protein kinases and CPP32-like protease pathways. Cell Immunol 194: 36 46.
17. Kermorvant-Duchemin E, Sennlaub F, Sirinyan M, Brault S, Andelfinger G, Kooli A et al. (2005). Trans-arachidonic acids generated during nitrative stress induce a thrombospondin-1-dependent microvascular degeneration. Nature Med 11: 1339 1345.
18. Kim H, Shim J, Han PL, Choi EJ (1997). Nitric oxide modulates the c-Jun N-terminal kinase/stress-activated protein kinase activity through activating c-Jun N-terminal kinase kinase. Biochemistry 36: 13677 13681.
19. Kim SJ, Ju JW, Oh CD, Yoon YM, Song WK, Lim JH et al. (2002). ERK1/2 and p38 kinase oppositely regulate nitric oxide-induced apoptosis of chondrocytes in association with p53, caspase-3 and differentiation status. J Biol Chem 277: 1332 1339.
20. Kim SO, Xu YJ, Katz S, Pelech S (2000). Cyclic GMP-dependent and -independent regulation of MAP kinases by sodium nitroprusside in isolated cardiomyocytes. Biochim Biophys Acta 1498: 277 284.
21. von Knethen A, Brune B (1997). Cyclooxygenase-2: an essential regulator of NO-mediated apoptosis. FASEB J 11: 887 895.
22. ras interaction. J Biol Chem 272: 4323 4326.
23. Livak KJ, Schmittgen TD (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402 408.
24. Marden NY, Murray M (2005). Characterisation of a c-Jun - responsive module in the 5′flank of the human CYP2J2 gene that regulates transactivation. Biochem J 391: 631 640.
25. Marden NY, Fiala-Beer E, Xiang SH, Murray M (2003). Role of activator protein-1 in the down-regulation of the human CYP2J2 gene in hypoxia. Biochem J 373: 669 680.
26. Murray M, Zaluzny L, Farrell GC (1986). Drug Metabolism in cirrhosis: selective changes in cytochrome P-450 isozymes in the choline-deficient rat model. Biochem Pharmacol 35: 1817 1824.
27. Node K, Huo Y, Ruan X, Yang B, Spieker M, Ley K et al. (1999). Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids. Science 285: 1276 1279.
28. Pfeilschifter J, Huwiler A (1996). Nitric oxide stimulates stress-activated protein kinases in glomerular endothelial and mesangial cells. FEBS Lett 396: 67 70.
29. Pilz RB, Suhasini M, Idriss S, Meinkoth JL, Boss GR (1995). Nitric oxide and cGMP analogs activate transcription from AP-1-responsive promoters in mammalian cells. FASEB J 9: 552 558.
30. Plachta N, Traister A, Weil M (2003). Nitric oxide is involved in establishing the balance between cell cycle progression and cell death in the developing neural tube. Exp Cell Res 288: 354 362.
31. Kip1. J Biol Chem 278: 29629 29625.
32. Roman RJ (2002). P450 metabolites of arachidonic acid in the control of cardiovascular function. Physiol Rev 82: 131 185.
33. Taimor G, Rakow A, Piper HM (2001). Transcription activator protein 1 (AP-1) mediates NO-induced apoptosis of adult cardiomyocytes. FASEB J 15: 2518 2520.
34. Treisman R (1996). Regulation of transcription by MAP kinase cascades. Curr Opin Cell Biol 8: 205 215.
35. VanRollins M, Kaduce TL, Knapp HR, Spector AA (1993). 14,15-Epoxyeicosatrienoic acid metabolism in endothelial cells. J Lipid Res 34: 1931 1942.
36. Wang P, Zweier JL (1996). Measurement of nitric oxide and peroxynitrite generation in the postischemic heart. J Biol Chem 271: 29223 29230.
37. Wu S, Moomaw CR, Tomer KB, Falck JR, Zeldin DC (1996). Molecular cloning and expression of CYP2J2, a human cytochrome P450 arachidonic acid epoxygenase highly expressed in heart. J Biol Chem 271: 3460 3468.
38. Yamazaki H, Okayama A, Imai N, Guengerich FP, Shimizu M (2006). Inter-individual variation of cytochrome P4502J2 expression and catalytic activities in liver microsomes from Japanese and Caucasian populations. Xenobiotica 36: 1201 1209.
39. Yang B, Graham L, Dikalov S, Mason RP, Falck JP, Liao JK et al. (2001). Overexpression of cytochrome P450 CYP2J2 protects against hypoxia-reoxygenation injury in cultured bovine aortic endothelial cells. Mol Pharmacol 60: 310 320.
40. Zeldin DC, Moomaw CR, Jesse N, Tomer KB, Beetham J, Hammock BD et al. (1996). Biochemical characterization of the human liver Cytochrome P450 arachidonic acid epoxygenase pathway. Arch Biochem Biophys 330: 87 96.
41. Zeldin DC, Foley J, Boyle JE, Moomaw CR, Tomer KB, Parker C et al. (1997a) Predominant expression of an arachidonate epoxygenase in islets of Langerhans cells in human and rat pancreas. Endocrinology 138: 1338 1346.
42. Zeldin DC, Foley J, Goldsworthy SM, Cook ME, Boyle JE, Ma J et al. (1997b) CYP2J subfamily cytochrome P450s in the gastrointestinal tract: expression, localization, and potential functional significance. Mol Pharmacol 51: 931 943.